Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinzhen oral liquid versus ambromoterol oral solution for acute bronchitis in children
ChiCTR2000034703Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Aug 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jinzhen in acute bronchitis (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Disappearance time of cough. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
Jinzhen
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on ChiCTR2000034703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034703.